Loading...
Loading...
India's vaccine imports from HUNGARY total $4.8B across 61 shipments from 2 foreign suppliers. CEVA SANTE ANIMALE leads with $4.8B in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include CEVA POLCHEM PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for vaccine — a concentrated sourcing relationship with select suppliers from HUNGARY.

CEVA SANTE ANIMALE is the leading Vaccine supplier from HUNGARY to India, with import value of $4.8B across 50 shipments. The top 5 suppliers — CEVA SANTE ANIMALE, CEVA-PHYLAXIA VETERINARY BIOLOGICALS CO LTD. — collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | CEVA SANTE ANIMALE | $4.8B | 50 | 100.0% |
| 2 | CEVA-PHYLAXIA VETERINARY BIOLOGICALS CO LTD. | $248 | 11 | 0.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | CEVA POLCHEM PRIVATE LIMITED | $4.8B | 61 | 100.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Vaccine suppliers from HUNGARY to India include CEVA SANTE ANIMALE, CEVA-PHYLAXIA VETERINARY BIOLOGICALS CO LTD.. The leading supplier is CEVA SANTE ANIMALE with import value of $4.8B USD across 50 shipments. India imported Vaccine worth $4.8B USD from HUNGARY in total across 61 shipments.
India imported Vaccine worth $4.8B USD from HUNGARY across 61 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Vaccine sourced from HUNGARY include CEVA POLCHEM PRIVATE LIMITED. The largest buyer is CEVA POLCHEM PRIVATE LIMITED with $4.8B in imports across 61 shipments.
The total value of Vaccine imports from HUNGARY to India is $4.8B USD, across 61 shipments and 2 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
61 Verified Shipments
2 suppliers, 1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists